Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Acquisitions (2020 - 2025)

Historic Acquisitions for Health Catalyst (HCAT) over the last 6 years, with Q2 2025 value amounting to -$8000.0.

  • Health Catalyst's Acquisitions fell 10004.29% to -$8000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year increase of 33.34%. This contributed to the annual value of $80.3 million for FY2024, which is 60467.87% up from last year.
  • As of Q2 2025, Health Catalyst's Acquisitions stood at -$8000.0, which was down 10004.29% from $41.1 million recorded in Q1 2025.
  • Health Catalyst's 5-year Acquisitions high stood at $46.8 million for Q3 2021, and its period low was -$8000.0 during Q2 2025.
  • Moreover, its 5-year median value for Acquisitions was $18.7 million (2024), whereas its average is $23.0 million.
  • Per our database at Business Quant, Health Catalyst's Acquisitions soared by 12285.81% in 2024 and then plummeted by 10004.29% in 2025.
  • Health Catalyst's Acquisitions (Quarter) stood at $46.8 million in 2021, then tumbled by 80.03% to $9.3 million in 2022, then grew by 22.01% to $11.4 million in 2023, then skyrocketed by 122.86% to $25.4 million in 2024, then crashed by 100.03% to -$8000.0 in 2025.
  • Its Acquisitions was -$8000.0 in Q2 2025, compared to $41.1 million in Q1 2025 and $25.4 million in Q4 2024.